SCHEMBL31304574

SCHEMBL31304574

CC(C)n1ncc2cc([N+](=O)[O-])ccc21

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GLS O94925 1/20 0.55
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
CYP19A1 P11511 1/20 0.43
MAPT P10636 6/20 0.42
NOS1 P29475 2/20 0.42
POLB P06746 1/20 0.42
MAOB P27338 1/20 0.42
KDR P35968 1/20 0.40
SLC6A2 P23975 1/20 0.40
CYP1A2 P05177 1/20 0.40
ACLY P53396 1/20 0.40
LMNA P02545 2/20 0.39
CYP3A4 P08684 1/20 0.39
ALOX15 P16050 1/20 0.39
ALDH1A1 P00352 3/20 0.39
HPGD P15428 1/20 0.39
TSHR P16473 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
TXNRD1 Q16881 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5352816 1.00 GLS (0.55) GLSMEN1KMT2ACYP19A1MAPT
SCHEMBL25273981 0.88 GLS (0.52) GLSMEN1KMT2ACYP19A1MAPT
SCHEMBL31510404 0.88 GLS (0.45) GLSMEN1KMT2AMAPTNOS1
SCHEMBL2144733 0.88 GLS (0.45) GLSMEN1KMT2AMAPTNOS1
SCHEMBL5382257 0.86 GLS (0.53) GLSMEN1KMT2ACYP19A1MAPT
SCHEMBL30475930 0.85 GLS (0.55) GLSMEN1KMT2ACYP19A1MAPT
SCHEMBL26805408 0.85 GLS (0.55) GLSMEN1KMT2ACYP19A1MAPT
SCHEMBL5341881 0.80 INMT (0.41) GLSMEN1KMT2AMAPTCYP1A2
SCHEMBL271762 0.80 GLS (0.62) GLSMEN1KMT2ACYP19A1MAPT
SCHEMBL29661255 0.80 GLS (0.62) GLSMEN1KMT2ACYP19A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4724443-A1 PYRAZOLO-PYRIMIDINONE COMPOUNDS FOR USE IN METHODS OF INHIBITING WEE1 A KINASE Acrivon Therapeutics, Inc. (US) 2026-04-15 EP disclosed
WO-2024254490-A1 PYRAZOLO-PYRIMIDINONE COMPOUNDS FOR USE IN METHODS OF INHIBITING WEE1 A KINASE ACRIVON THERAPEUTICS, INC. (US) 2024-12-12 WO disclosed